A detailed analysis of these rAd5-based trials showed a strong activation of Ad5-specific (but not HIV-specific) CD4 T cells in the gut mucosa of vaccinees, which may explain their enhanced susceptibility to infection (48), a finding reproduced in the monkey model (49). The gene discussed is CD4; the disease is infection.